Cargando…
AMPKα Is Suppressed in Bladder Cancer through Macrophage-Mediated Mechanisms()()
Bladder cancer presents as either low- or high-grade disease, each with distinct mutational profiles; however, both display prominent mTORC1 activation. One major negative regulator of mTORC1 is AMPK, which is a critical metabolic regulator that suppresses cellular growth in response to metabolic st...
Autores principales: | Kopsiaftis, Stavros, Hegde, Poornima, Taylor, John A., Claffey, Kevin P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5143351/ https://www.ncbi.nlm.nih.gov/pubmed/27916296 http://dx.doi.org/10.1016/j.tranon.2016.07.007 |
Ejemplares similares
-
Null mutation for Macrophage Migration Inhibitory Factor (MIF) is associated with less aggressive bladder cancer in mice
por: Taylor, John A, et al.
Publicado: (2007) -
A RAS-CaMKKβ-AMPKα2 pathway promotes senescence by licensing post-translational activation of C/EBPβ through a novel 3′UTR mechanism
por: Basu, Sandip K., et al.
Publicado: (2018) -
Bladder Cancer versus Hemorrhagic Cystitis: A Case of Mistaken Identity in a 34-Year-Old Male Undergoing Therapy for Granulomatosis with Polyangiitis
por: Amatruda, Jonathan, et al.
Publicado: (2014) -
Metformin suppresses adipogenesis through both AMP-activated protein kinase (AMPK)-dependent and AMPK-independent mechanisms
por: Chen, Suet Ching, et al.
Publicado: (2017) -
Impairment of AMPK-α2 augments detrusor contractions in bladder ischemia
por: Yang, Jing-Hua, et al.
Publicado: (2021)